Literature DB >> 23448214

Iron accumulation in multiple sclerosis: an early pathogenic event.

Steven M LeVine1, Mehmet Bilgen, Sharon G Lynch.   

Abstract

Iron has been shown to accumulate in deep gray matter structures in many forms of multiple sclerosis (MS), but detecting its presence early in the disease course (e.g., clinically isolated syndrome [CIS]) has been less clear. Here, we review a recent study where MRI scanning at 7 T together with susceptibility mapping was performed to assess iron deposition in CIS and control subjects. Susceptibility indicative of iron deposition was found to be increased in the globus pallidus, caudate, putamen and pulvinar of CIS patients compared with controls. The findings suggest that iron deposition is a pathological change that occurs early in the development of MS. Identifying the mechanisms of iron accumulation and determining whether iron promotes pathogenesis in MS are important areas of future research.

Entities:  

Year:  2013        PMID: 23448214     DOI: 10.1586/ern.13.14

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  6 in total

1.  Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection.

Authors:  Vanessa Kappel da Silva; Betânia Souza de Freitas; Arethuza da Silva Dornelles; Laura Roesler Nery; Lucio Falavigna; Rafael Dal Ponte Ferreira; Maurício Reis Bogo; Jaime Eduardo Cecílio Hallak; Antônio Waldo Zuardi; José Alexandre S Crippa; Nadja Schröder
Journal:  Mol Neurobiol       Date:  2013-07-28       Impact factor: 5.590

2.  Can T2 blackout effect be a marker of iron accumulation in brains of multiple sclerosis patients?

Authors:  Mehmet Fatih Erbay; Özden Kamışlı; Nur Betül Karatoprak
Journal:  Br J Radiol       Date:  2020-07-08       Impact factor: 3.039

3.  Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.

Authors:  Antonia Janssen; Sebastian Fiebiger; Helena Bros; Laura Hertwig; Silvina Romero-Suarez; Isabell Hamann; Coralie Chanvillard; Judith Bellmann-Strobl; Friedemann Paul; Jason M Millward; Carmen Infante-Duarte
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

Review 4.  Iron chelation and multiple sclerosis.

Authors:  Kelsey J Weigel; Sharon G Lynch; Steven M LeVine
Journal:  ASN Neuro       Date:  2014-01-30       Impact factor: 4.146

5.  A Distinct Hibiscus sabdariffa Extract Prevents Iron Neurotoxicity, a Driver of Multiple Sclerosis Pathology.

Authors:  Manoj Kumar Mishra; Jianxiong Wang; Reza Mirzaei; Rigel Chan; Helvira Melo; Ping Zhang; Chang-Chun Ling; Aldo Bruccoleri; Lin Tang; V Wee Yong
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

6.  Iron deposition in multiple sclerosis: overall load or distribution alteration?

Authors:  Eman Hamdy; Aya Abdel Galeel; Ismail Ramadan; Dina Gaber; Haytham Mustafa; Jaidaa Mekky
Journal:  Eur Radiol Exp       Date:  2022-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.